Facultad de Farmacia
Zentrum
Hospital Universitario Central de Asturias
Oviedo, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Central de Asturias (9)
2024
-
Sphingosine 1-phosphate receptor subtype 1 (S1P1) activity in the course of Alzheimer's disease
Neurobiology of Disease, Vol. 202
2022
-
New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's Disease
International journal of molecular sciences, Vol. 23, Núm. 16
2021
-
Long runs of homozygosity are associated with Alzheimer’s disease
Translational Psychiatry, Vol. 11, Núm. 1
2019
-
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project
Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347
2018
-
Targeting beta-amyloid at the CSF: A new therapeutic strategy in Alzheimer's disease
Frontiers in Aging Neuroscience, Vol. 10, Núm. APR
2015
-
MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium
Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 343-352
2014
-
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia
Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4
2009
-
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Nature Genetics, Vol. 41, Núm. 10, pp. 1094-1099
-
Lrrk2 R1441G-related Parkinson's disease: Evidence of a common founding event in the seventh century in Northern Spain
Neurogenetics, Vol. 10, Núm. 4, pp. 347-353